3 Health Services Stocks Nudging The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 16 points (0.1%) at 16,738 as of Wednesday, June 4, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,399 issues advancing vs. 1,611 declining with 145 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is up 0.1%. Top gainers within the industry include Omnicare ( OCR), up 3.2%, Smith & Nephew ( SNN), up 2.7%, Express Scripts ( ESRX), up 1.3%, Quest Diagnostics ( DGX), up 1.2% and Grifols ( GRFS), up 1.1%. A company within the industry that fell today was Boston Scientific ( BSX), up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. CareFusion ( CFN) is one of the companies pushing the Health Services industry higher today. As of noon trading, CareFusion is up $0.60 (1.4%) to $43.68 on average volume. Thus far, 741,791 shares of CareFusion exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $42.95-$43.72 after having opened the day at $43.06 as compared to the previous trading day's close of $43.07.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. CareFusion has a market cap of $8.9 billion and is part of the health care sector. Shares are up 8.2% year-to-date as of the close of trading on Tuesday. Currently there are 5 analysts who rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Laboratory Corp of America Hldgs ( LH) is up $1.54 (1.5%) to $104.08 on average volume. Thus far, 518,277 shares of Laboratory Corp of America Hldgs exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $102.31-$104.21 after having opened the day at $102.31 as compared to the previous trading day's close of $102.54.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corp of America Hldgs has a market cap of $8.7 billion and is part of the health care sector. Shares are up 12.2% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts who rate Laboratory Corp of America Hldgs a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Laboratory Corp of America Hldgs as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corp of America Hldgs Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, WellPoint ( WLP) is up $0.80 (0.7%) to $108.81 on light volume. Thus far, 690,797 shares of WellPoint exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $107.80-$108.85 after having opened the day at $108.14 as compared to the previous trading day's close of $108.01.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $30.3 billion and is part of the health care sector. Shares are up 16.9% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts who rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Comcast Considering All-Cash Bid for Fox as Disney Battle Heads to the Wire

Comcast Considering All-Cash Bid for Fox as Disney Battle Heads to the Wire

Target's Stock Tanks After Q1 Earnings Miss and Slowing Sales

Target's Stock Tanks After Q1 Earnings Miss and Slowing Sales

Stocks Trade Lower as Optimism Wanes Over China Trade Talks

Stocks Trade Lower as Optimism Wanes Over China Trade Talks

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Global Rally Stalls as Trump Doubts North Korea Summit, Questions China Trade

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know

Trump, China Trade, Target and Las Vegas Casinos - 5 Things You Must Know